Abstract
Atrial fibrillation (AF) tends to occur frequently in patients with thyroid disease, primarily hyperthyroidism. In hyperthyroidism, increased levels of thyroid hormones, via intra- and extranuclear mechanisms, have profound effects on cardiac electrophysiology. Hypothyroidism carries a lower risk for AF and is mainly associated with the overtreatment of hypothyroid patients. New-onset AF is frequently the only manifestation of thyroid disease, which renders screening for thyroid dysfunction in that scenario clinically useful. Managing thyroid disease and comorbid AF is essential. This includes thyroid hormones control along with conventional AF therapy. However, there are several open issues with this comorbid duo. The optimal management of thyroid disease and its impact on AF burden remains obscure. There is scanty information on clear-cut benefits for therapy of subclinical thyroid disease and screening of asymptomatic patients. Furthermore, the immunogenetic overlap between the autoantibodies in Graves’ disease and AF genesis may lead to novel therapeutic implications. The objective of this review is to summarize the up-to-date epidemiology, pathogenesis, pathophysiology and management of interacting thyroid disease and AF.
Similar content being viewed by others
Abbreviations
- AF:
-
Atrial Fibrillation
- TSH:
-
Thyroid-stimulating hormone/ thyrotropin
- T3:
-
Triiodothyronine
- T4:
-
Thyroxine
References
Madariaga AG, Santos Palacios S, Guillén-Grima F, Galofré JC. The incidence and prevalence of thyroid dysfunction in Europe: A meta-analysis. J Clin Endocrinol Metab. 2014;99(3):923–31. https://doi.org/10.1210/jc.2013-2409.
Grossman A, Weiss A, Koren-Morag N, Shimon I, Beloosesky Y, Meyerovitch J. Subclinical Thyroid Disease and Mortality in the Elderly: A Retrospective Cohort Study. Am J Med. 2016;129(4):423–30. https://doi.org/10.1016/j.amjmed.2015.11.027.
Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter: A population-based study. Arch Intern Med. 2004;164(15):1675–8. https://doi.org/10.1001/archinte.164.15.1675.
Jia G, Sowers JR. Autoantibodies of β-adrenergic and M2 cholinergic receptors: atrial fibrillation in hyperthyroidism. Endocrine. 2015;49(2):301–3. https://doi.org/10.1007/s12020-015-0556-3.
Peeters RP. Subclinical Hypothyroidism. Solomon CG, ed. N Engl J Med. 2017;376(26):2556–2565. https://doi.org/10.1056/NEJMcp1611144
Grais IM, Sowers JR. Thyroid and the heart. Am J Med. 2014;127(8):691–8. https://doi.org/10.1016/j.amjmed.2014.03.009.
Bellew SD, Moman R, Lohse CM, Hess EP, Bellolio MF. Validation of a decision rule for selective TSH screening in atrial fibrillation. West J Emerg Med. 2015;16(1):195–202. https://doi.org/10.5811/westjem.2014.11.23490.
Croker EE, McGrath SA, Rowe CW. Thyroid disease: Using diagnostic tools effectively. Aust J Gen Pract. 2021;50(1–2):16–21. https://doi.org/10.31128/AJGP-10-20-5693
Salem JE, Shoemaker MB, Bastarache L, et al. Association of Thyroid Function Genetic Predictors with Atrial Fibrillation: A Phenome-Wide Association Study and Inverse-Variance Weighted Average Meta-analysis. JAMA Cardiol. 2019;4(2):136–43. https://doi.org/10.1001/jamacardio.2018.4615.
Fitzgerald SP, Bean NG, Falhammar H, Tuke J. Clinical Parameters Are More Likely to Be Associated with Thyroid Hormone Levels than with Thyrotropin Levels: A Systematic Review and Meta-Analysis. Thyroid. 2020;30(12):1695–709. https://doi.org/10.1089/thy.2019.0535.
Baumgartner C, Da Costa BR, Collet TH, et al. Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation. Circulation. 2017;136(22):2100–16. https://doi.org/10.1161/CIRCULATIONAHA.117.028753.
Gammage MD, Parle JV, Holder RL, et al. Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med. 2007;167(9):928–34. https://doi.org/10.1001/archinte.167.9.928.
Yeap BB, Alfonso H, Hankey GJ, et al. Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men: The Health in Men Study. Eur J Endocrinol. 2013;169(4):401–8. https://doi.org/10.1530/EJE-13-0306.
Amouzegar A, Heidari M, Gharibzadeh S, Mehran L, Tohidi M, Azizi F. The Association between Blood Pressure and Normal Range Thyroid Function Tests in a Population Based Tehran Thyroid Study. Horm Metab Res. 2016;48(3):151–6. https://doi.org/10.1055/s-0035-1564131.
Cappola AR, Fried L, Arnold A. Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults. Surv Anesthesiol. 2006;50(6):289. https://doi.org/10.1097/01.sa.0000248434.75521.67.
Chaker L, Korevaar TIM, Medici M, et al. Thyroid Function Characteristics and Determinants: The Rotterdam Study. Thyroid. 2016;26(9):1195–204. https://doi.org/10.1089/thy.2016.0133.
Anderson JL, Jacobs V, May HT, et al. Free thyroxine within the normal reference range predicts risk of atrial fibrillation. J Cardiovasc Electrophysiol. 2020;31(1):18–29. https://doi.org/10.1111/jce.14183.
Reddy V, Taha W, Kundumadam S, Khan M. Atrial fibrillation and hyperthyroidism: A literature review. Indian Heart J. 2017;69(4):545–50. https://doi.org/10.1016/j.ihj.2017.07.004.
Selmer C, Olesen JB, Hansen ML, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: A large population cohort study. BMJ. 2012;345(7885):1–12. https://doi.org/10.1136/bmj.e7895.
Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH. 2018 European thyroid association guideline for the management of graves’ hyperthyroidism. Eur Thyroid J. 2018;7(4):167–86. https://doi.org/10.1159/000490384.
Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart. Endocr Rev. 2005;26(5):704–28. https://doi.org/10.1210/er.2003-0033.
Razvi S, Jabbar A, Pingitore A, et al. Thyroid Hormones and Cardiovascular Function and Diseases. J Am Coll Cardiol. 2018;71(16):1781–96. https://doi.org/10.1016/j.jacc.2018.02.045.
Wijesurendra RS, Casadei B. Mechanisms of atrial fibrillation. Heart. 2019;105(24):1860–7. https://doi.org/10.1136/heartjnl-2018-314267.
Biondi B. Heart failure and thyroid dysfunction. Eur J Endocrinol. 2012;167(5):609–18. https://doi.org/10.1530/EJE-12-0627.
Shi M, Manouchehri AM, Shaffer CM, et al. Genetic Thyrotropin Regulation of Atrial Fibrillation Risk Is Mediated Through an Effect on Height. J Clin Endocrinol Metab. 2021;106(7):2124–32. https://doi.org/10.1210/clinem/dgab272.
Tribulova N, Kurahara LH, Hlivak P, Hirano K, Bacova BS. Pro-arrhythmic signaling of thyroid hormones and its relevance in subclinical hyperthyroidism. Int J Mol Sci. 2020;21(8). https://doi.org/10.3390/ijms21082844
Kato T, Iwasaki YK, Nattel S. Connexins and atrial fibrillation: Filling in the gaps. Circulation. 2012;125(2):203–6. https://doi.org/10.1161/CIRCULATIONAHA.111.075432.
Komiya N, Isomoto S, Nakao K, Hayano M, Yano K. Electrophysiological abnormalities of the atrial muscle in patients with paroxysmal atrial fibrillation associated with hyperthyroidism. Clin Endocrinol (Oxf). 2002;56(1):39–44. https://doi.org/10.1046/j.0300-0664.2001.01459.x.
Wustmann K, Kucera JP, Zanchi A, et al. Activation of electrical triggers of atrial fibrillation in hyperthyroidism. J Clin Endocrinol Metab. 2008;93(6):2104–8. https://doi.org/10.1210/jc.2008-0092.
Patanè S, Marte F. Atrial fibrillation associated with exogenous subclinical hyperthyroidism, changing axis deviation, troponin-I positive and without acute coronary syndrome. Int J Cardiol. 2011;150(3):e85–8. https://doi.org/10.1016/j.ijcard.2009.03.011.
Chen YC, Chen SA, Chen YJ, Chang MS, Chan P, Lin CI. Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol. 2002;39(2):366–72. https://doi.org/10.1016/S0735-1097(01)01731-4.
Po SS, Scherlag BJ, Yamanashi WS, et al. Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions. Hear Rhythm. 2006;3(2):201–8. https://doi.org/10.1016/j.hrthm.2005.11.008.
Ertek S, Cicero AF. State of the art paper Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology. Arch Med Sci. 2013;5:944–52. https://doi.org/10.5114/aoms.2013.38685.
Morshed SA, Davies TF. Graves’ Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies. Horm Metab Res. 2015;47(10):727–34. https://doi.org/10.1055/s-0035-1559633.
Okosieme OE, Taylor PN, Evans C, et al. Primary therapy of Graves’ disease and cardiovascular morbidity and mortality: a linked-record cohort study. Lancet Diabetes Endocrinol. 2019;7(4):278–87. https://doi.org/10.1016/S2213-8587(19)30059-2.
Li H, Murphy T, Zhang L, et al. β1-Adrenergic and M2 muscarinic autoantibodies and thyroid hormone facilitate induction of atrial fibrillation in male rabbits. Endocrinology. 2016;157(1):16–22. https://doi.org/10.1210/en.2015-1655.
Galloway A, Li H, Vanderlinde-Wood M, et al. Activating autoantibodies to the β1/2-adrenergic and M2 muscarinic receptors associate with atrial tachyarrhythmias in patients with hyperthyroidism. Endocrine. 2015;49(2):457–63. https://doi.org/10.1007/s12020-014-0495-4.
Stavrakis S, Yu X, Patterson E, et al. Activating Autoantibodies to the Beta-1 Adrenergic and M2 Muscarinic Receptors Facilitate Atrial Fibrillation in Patients With Graves’ Hyperthyroidism. J Am Coll Cardiol. 2009;54(14):1309–16. https://doi.org/10.1016/j.jacc.2009.07.015.
Park YJ, Yoon JW, Kim K Il, et al. Subclinical Hypothyroidism Might Increase the Risk of Transient Atrial Fibrillation After Coronary Artery Bypass Grafting. Ann Thorac Surg. 2009;87(6):1846–1852. https://doi.org/10.1016/j.athoracsur.2009.03.032
Lee H-C, Huang KTL, Wang X-L, Shen W-K. Autoantibodies and Cardiac Arrhythmias. Hear Rhythm. 2011;8(11):1788–95. https://doi.org/10.1016/j.hrthm.2011.06.032.
Li J. The Role of Autoantibodies in Arrhythmogenesis. Curr Cardiol Rep. 2021;23(1). https://doi.org/10.1007/s11886-020-01430-x
Li Z, Zhao H, Wang J. Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities. Front Cardiovasc Med. 2021;8: 650278. https://doi.org/10.3389/fcvm.2021.650278.
Ozaydin M, Kutlucan A, Turker Y, et al. Association of inflammation with atrial fibrillation in hyperthyroidism. J Geriatr Cardiol. 2012;9(4):344–8. https://doi.org/10.3724/SP.J.1263.2012.06251.
Elahi MM, Flatman S, Matata BM. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon. Eur J Cardiovasc Prev Rehabil. 2008;15(6):735–41. https://doi.org/10.1097/HJR.0b013e328317f38a.
Pearce EN, Bogazzi F, Martino E, et al. The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. Thyroid. 2003;13(7):643–8. https://doi.org/10.1089/105072503322239989.
Mayyas F, Saadeh N, Al-Muqbel K, Van Wagoner DR. Plasma endothelin-1 levels are increased in atrial fibrillation patients with hyperthyroidism. PLoS One. 2018;13(12). https://doi.org/10.1371/journal.pone.0208206
Lu R, Ma N, Jiang Z, Mei J. Endothelin-1 is associated with dilatation of the left atrium and can be an independent predictor of atrial fibrillation after mitral valve surgery. Interact Cardiovasc Thorac Surg. 2018;26(1):66–70. https://doi.org/10.1093/icvts/ivx250.
Tilly N, Schneider J, Leidig-Bruckner G, Sommer U, Kasperk C. Endothelin-1 Levels in Patients with Disorders of the Thyroid Gland. Exp Clin Endocrinol Diabetes. 2003;111(02):80–4. https://doi.org/10.1055/s-2003-39234.
Mayyas F, Niebauer M, Zurick A, et al. Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. Circ Arrhythmia Electrophysiol. 2010;3(4):369–79. https://doi.org/10.1161/CIRCEP.109.924985.
Bielecka-Dabrowa A, Mikhailidis DP, Rysz J, Banach M. The mechanisms of atrial fibrillation in hyperthyroidism. Thyroid Res. 2009;2(1):4. https://doi.org/10.1186/1756-6614-2-4.
Patanè S, Marte F. Atrial fibrillation associated with exogenous subclinical hyperthyroidism, changing axis deviation, troponin-I positive and without acute coronary syndrome. Int J Cardiol. 2011;150(3). https://doi.org/10.1016/j.ijcard.2009.03.011
Sawin CT. Subclinical hyperthyroidism and atrial fibrillation. Thyroid. 2002;12(6):501–3. https://doi.org/10.1089/105072502760143881.
Selmer C, Olesen JB, Hansen ML, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: A large population cohort study. BMJ. 2012;345(7885). https://doi.org/10.1136/bmj.e7895
Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J. 2001;142(5):838–42. https://doi.org/10.1067/mhj.2001.119370.
Goldstein SA, Green J, Huber K, et al. Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial). Am J Cardiol. 2019;124(9):1406–12. https://doi.org/10.1016/j.amjcard.2019.07.046.
Ogbera A, Dada O, Kuku S. The metabolic syndrome in thyroid disease: A report from Nigeria. Indian J Endocrinol Metab. 2012;16(3):417. https://doi.org/10.4103/2230-8210.95688.
Benjamin EJ, Levy D, Vaziri SM, D’agostino RB, Belanger AJ, Wolf PA. Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort: The Framingham Heart Study. JAMA J Am Med Assoc. 1994;271(11):840–4. https://doi.org/10.1001/jama.1994.03510350050036.
Chauhan V. Hypothyroidism was 300% more frequent than hyperthyroidism in patients with atrial fibrillation enrolled over 10 years. Am J Med. 2015;128(10): e51. https://doi.org/10.1016/j.amjmed.2015.06.012.
Zhang Y, Dedkov EI, Teplitsky D, et al. Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats. Circ Arrhythmia Electrophysiol. 2013;6(5):952–9. https://doi.org/10.1161/CIRCEP.113.000502.
Gerritsen RJ, van den Brom WE, Stokhof AA. Relationship between atrial fibrillation and primary hypothyroidism in the dog. Vet Q. 1996;18(2):49–51. https://doi.org/10.1080/01652176.1996.9694614.
Kim E-J, Lyass A, Wang N. Relation of Hypothyroidism and Incident Atrial Fibrillation (from the Framingham Heart Study). Bone. 2008;23(1):1–7. https://doi.org/10.1016/j.ahj.2013.10.012.Relation.
Papaleontiou M, Haymart MR. Too Much of a Good Thing? A Cautionary Tale of Thyroid Cancer Overdiagnosis and Overtreatment. Thyroid. 2020;30(5):651–2. https://doi.org/10.1089/thy.2020.0185.
Lee EK, Ahn HY, Ku EJ, et al. Cardiovascular Outcomes in Thyroid Cancer Patients Treated With Thyroidectomy: A Meta-Analysis. J Clin Endocrinol Metab. Published online August 4, 2021:1–10. https://doi.org/10.1210/clinem/dgab576
Hesselink ENK, Lefrandt JD, Schuurmans EP, et al. Increased risk of atrial fibrillation after treatment for differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2015;100(12):4563–9. https://doi.org/10.1210/jc.2015-2782.
Surks MI, Ortiz E, Daniels GH, et al. Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management. J Am Med Assoc. 2004;291(2):228–38. https://doi.org/10.1001/jama.291.2.228.
Gencer B, Collet TH, Virgini V, et al. Subclinical thyroid dysfunction and the risk of heart failure events an individual participant data analysis from 6 prospective cohorts. Circulation. 2012;126(9):1040–9. https://doi.org/10.1161/CIRCULATIONAHA.112.096024.
Martínez-Comendador J, Marcos-Vidal JM, Gualis J, et al. Subclinical Hypothyroidism Might Increase the Risk of Postoperative Atrial Fibrillation after Aortic Valve Replacement. Thorac Cardiovasc Surg. 2016;64(5):427–33. https://doi.org/10.1055/s-0035-1555753.
Sairaku A, Nakano Y, Uchimura Y, et al. Increased left atrial pressure in non-heart failure patients with subclinical hypothyroidism and atrial fibrillation. Endocr Connect. 2016;5(3):101–6. https://doi.org/10.1530/EC-16-0012.
Isaksen JL, Skov MW, Graff C, Ellervik C, Kanters JK. Electrocardiography in euthyroid individuals: a Danish general population study. Minerva Endocrinol 2020 Jul 23. https://doi.org/10.23736/S0391-1977.20.03170-3
Tayal B, Graff C, Selmer C, et al. Thyroid dysfunction and electrocardiographic changes in subjects without arrhythmias: A cross-sectional study of primary healthcare subjects from Copenhagen. BMJ Open. 2019;9(6):1–10. https://doi.org/10.1136/bmjopen-2018-023854.
Chen JL, Chiu HW, Tseng YJ, Chu WC. Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: Evidence from spectral analysis of heart rate variability. Clin Endocrinol (Oxf). 2006;64(6):611–6. https://doi.org/10.1111/j.1365-2265.2006.02514.x.
Burggraaf J, Tulen JHM, Lalezari S, et al. Sympathovagal imbalance in hyperthyroidism. Am J Physiol Metab. 2001;281(1):E190–5. https://doi.org/10.1152/ajpendo.2001.281.1.E190.
Selmer C, Hansen ML, Olesen JB, et al. New-Onset Atrial Fibrillation Is a Predictor of Subsequent Hyperthyroidism: A Nationwide Cohort Study. PLoS One. 2013;8(2). https://doi.org/10.1371/journal.pone.0057893
Krahn AD, Klein GJ, Kerr CR, et al. How useful is thyroid function testing in patients with recent-onset atrial fibrillation? Arch Intern Med. 1996;156(19):2221–4. https://doi.org/10.1001/archinte.156.19.2221.
Heeringa J, Hoogendoorn EH, van der Deure WM, et al. High-Normal Thyroid Function and Risk of Atrial Fibrillation. Arch Intern Med. 2008;168(20):2219. https://doi.org/10.1001/archinte.168.20.2219.
Zych J, Guerriaud M, Michiels Y. Amiodarone and thyroid dysfunction. Actual Pharm. 2019;58(591):46–8. https://doi.org/10.1016/j.actpha.2019.10.012.
Batcher EL, Tang XC, Singh BN, Singh SN, Reda DJ, Hershman JM. Thyroid Function Abnormalities during Amiodarone Therapy for Persistent Atrial Fibrillation. Am J Med. 2007;120(10):880–5. https://doi.org/10.1016/j.amjmed.2007.04.022.
Lewandowski K. Reference ranges for TSH and thyroid hormones. Thyroid Res. 2015;8(Suppl 1):A17. https://doi.org/10.1186/1756-6614-8-s1-a17.
Shimizu T, Koide S, Noh JY, Sugino K, Ito K, Nakazawa H. Hyperthyroidism and the management of atrial fibrillation. Thyroid. 2002;12(6):489–93. https://doi.org/10.1089/105072502760143863.
Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: Management guidelines of the american thyroid association and American association of clinical endocrinoloigists. Endocr Pract. 2011;17(3):456–520. https://doi.org/10.4158/EP.17.3.456.
Sivanandy P, Mey LC. Management of thyrotoxicosis with atrial fibrillation - A case report. J Young Pharm. 2017;9(4):616–9. https://doi.org/10.5530/jyp.2017.9.117.
Burr WA, Griffiths RS, Ramsden DB, et al. Effect of a single dose of dexamethasone on serum concentrations of thyroid hormones. Lancet. 1976;308(7976):58–61. https://doi.org/10.1016/S0140-6736(76)92283-2.
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373–498. https://doi.org/10.1093/eurheartj/ehaa612.
De Souza MVL, Duarte MMT, Coeli CM, Vaisman M. Atrial fibrillation and hyperthyroidism: Relation between transoesophageal markers of a thrombogenic milieu and clinical risk factors for thromboembolism. Clin Endocrinol (Oxf). 2012;76(3):448–53. https://doi.org/10.1111/j.1365-2265.2011.04232.x.
Friberg L, Rosenqvist M, Lip GYH. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: The Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33(12):1500–10. https://doi.org/10.1093/eurheartj/ehr488.
Gorenek B, Boriani G, Dan GA, et al. European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS). Europace. 2018;20(6):895–6. https://doi.org/10.1093/europace/euy051.
Naccarelli GV, Dell’Orfano JT, Wolbrette DL, Patel HM, Luck JC. Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy. Am J Cardiol. 2000;85(10):36–45. https://doi.org/10.1016/S0002-9149(00)00905-X.
Shah AJ, Liu X, Jadidi AS, Haïssaguerre M. Early management of atrial fibrillation: From imaging to drugs to ablation. Nat Rev Cardiol. 2010;7(6):345–54. https://doi.org/10.1038/nrcardio.2010.49.
Ma CS, Liu X, Hu FL, et al. Catheter ablation of atrial fibrillation in patients with hyperthyroidism. J Interv Card Electrophysiol. 2007;18(2):137–42. https://doi.org/10.1007/s10840-007-9088-y.
Siu CW, Jim MH, Zhang X, et al. Comparison of Atrial Fibrillation Recurrence Rates After Successful Electrical Cardioversion in Patients With Hyperthyroidism-Induced Versus Non-Hyperthyroidism-Induced Persistent Atrial Fibrillation. Am J Cardiol. 2009;103(4):540–3. https://doi.org/10.1016/j.amjcard.2008.10.019.
Wongcharoen W, Lin Y-J, Chang S-L, et al. History of hyperthyroidism and long-term outcome of catheter ablation of drug-refractory atrial fibrillation. Heart Rhythm. 2015;12(9):1956–62. https://doi.org/10.1016/j.hrthm.2015.06.004.
Nakazawa H, Lythall DA, Noh J, et al. Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation. Eur Heart J. 2000;21(4):327–33. https://doi.org/10.1053/euhj.1999.1956.
Acknowledgements
We want to thank Dr Stavros Zanos (Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research) for his significant scientific contribution to the manuscript. Dr Zanos thoroughly revised the manuscript and added substantial knowledge on the interaction between thyroid hormones and the autonomic nervous system, which predisposes to AF.
Funding
None declared.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interests/Competing interests
None declared.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bekiaridou, A., Kartas, A., Moysidis, D.V. et al. The bidirectional relationship of thyroid disease and atrial fibrillation: Established knowledge and future considerations. Rev Endocr Metab Disord 23, 621–630 (2022). https://doi.org/10.1007/s11154-022-09713-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11154-022-09713-0